Naperville, IL -- (SBWIRE) -- 07/31/2013 -- Reportstack, provider of premium market research reports announces the addition of Bulgaria Pharmaceuticals and Healthcare Report Q3 2013 market report to its offering
Executive Summary
According to industry sources, the Bulgarian pharmaceuticals market has reached a standstill.
This is expected to continue throughout 2013, due to the decline in drug prices and the stagnant health
insurance fund budget. We expect that the market will post single-digit value increase, on account of
inflationary pressures and continued volume demand. Political uncertainty will also add to the negative
pressures affecting the wider healthcare market.
Headline Expenditure Projections
? Pharmaceuticals: BGN2.22bn (US$1.46bn) in 2012 to BGN2.31bn (US$1.58bn) in 2013; +3.8% in
local currency terms and +8.0% in US dollar terms. Local currency forecast broadly in line with Q213
figures.
? Healthcare: BGN5.60bn (US$3.68bn) in 2012 to BGN5.77bn (US$3.94bn) in 2013; +3.0% in local
currency terms and +7.1% in US dollar terms. Local currency forecast broadly in line with Q213 figures,
despite slight upward revision of historical figures.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/138433/bulgaria-pharmaceuticals-and-healthcare-report-q3-2013.html

Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###